Janet Dunn

21.6k citations

253 papers · 11.2k indexed · 6 hit papers · h-index 46

Impact in

Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research

Papers in

Otorhinolaryngology 23
- Head and Neck Cancer Studies 23
Cancer Research 73
- Breast Cancer Treatment Studies 56
- Cancer Genomics and Diagnostics 18

Co-authors: John P. Neoptolemos Deborah Stocken F Lacaine D. Spooner Laureano Fernández‐Cruz Massimo Falconi Helen Hickey Andrea Marshall
Journals: Journal of Clinical Oncology (39 papers)Cancer Research (13 papers)British Journal of Cancer (13 papers)Annals of Oncology (10 papers)BJOG An International Journal of Obstetrics & Gynaecology (9 papers)
Partner nations: United Kingdom Canada United States

In The Last Decade

Janet Dunn

241 papers receiving 10.9k citations

Hit Papers

6 papers align trajectories log scale

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) 2018 · 855 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Journal of Clinical Oncology
2016 New England Journal of Medicine
2013 The Lancet Oncology
2009 Journal of Clinical Oncology
2004 New England Journal of Medicine
2001 The Lancet

Peers

Countries citing papers authored by Janet Dunn

Since Specialization

Citations

This map shows the geographic impact of Janet Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Dunn more than expected).

Fields of papers citing papers by Janet Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Dunn. The network helps show where Janet Dunn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Janet Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janet Dunn Line = papers co-authored together Janet Dunn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Volatile vs Total intravenous Anaesthesia for major non-cardiac surgery: a pragmatic randomised triaL (VITAL) Trials ·Joyce Yeung, Shaman Jhanji, John T. Braun, Janet Dunn, Lukáš Mohelský, Florentino Cardoso, Louise Hiller, Dong-Hao Gu, Monica Jefford, James Mason, Ramani Moonesinghe, Rupert M. Pearse, Ben Shelley, Cecilia Vindrola‐Padros, (unknown)	2024	2
2	Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial Cancers ·Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D Neal, Tim Planche, Kamaraj Karunanithi, Yoshiko Koda, Simon Stern, Zuzana Vlasáková, Lynch Vp, Scott Baker, Janet Dunn, Mark T. Drayson	2023	0
3	ATNEC – Patient Experience Sub-Study (IRSCTN: 36585784): What Patients Think About Taking Part In Breast Cancer Treatment De-Escalation Trials? The Breast ·Janet Dunn, Duyar, L. Remya, Mansi Ravindra Kolambe, Anna Eriksson-Trenter, Andrea P. Marshall, Hannah Jelley, Beatrix Elsberger, A.M. Cerri	2023	0
4	Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study SHILAP Revista de lepidopterología ·Alexander Anatolevich Dvirskii, Jennifer Heaney, Gulnaz Iqbal, Janet Dunn, Stella Bowcock, Tim Planche, Guy Pratt, Kwee Yong, Eric Low, Jill Wood, Kerry Raynes, Helen Higgins, Mark T. Drayson	2020	2
5	Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial British Journal of Haematology ·Catherine Atkin, Gulnaz Iqbal, Tim Planche, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Eric Low, Helen Higgins, Richard D Neal, Janet Dunn, Mark T. Drayson, Stella Bowcock, (unknown), (unknown)	2020	5
6	Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: A systematic review and evidence of a potential mechanism The Journal of Steroid Biochemistry and Molecular Biology ·Janet Dunn, Kieran Jefferson, Donald Macdonald, Gulnaz Iqbal, Rosemary Bland	2019	9
7	Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Journal of Clinical Oncology ·Annie Young, Andrea Marshall, G. Minarik, Oliver Chapman, Anand Lokare, Catherine St. Hill, Danielle Hale, Janet Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay K. Kakkar, Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher Poole, Anthony Maraveyas, Mark N. Levine Hit paper breakdown →	2018	855
8	Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the Select-D™ Pilot Trial Blood ·Annie Young, Andrea Marshall, Raouf Muayed, Catherine St. Hill, Danielle Hale, Janet Dunn, Anand Lokare, Ajay K. Kakkar, Mark N. Levine, Oliver Chapman	2017	23
9	Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer European Journal of Cancer ·Alison Smith, Peter Hall, Claire Hulme, Janet Dunn, Christopher C. McConkey, Joy K Rahman, Christopher McCabe, Hisham Mehanna	2017	27
10	Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel Clinical Cancer Research ·Jean Abraham, Qi Guo, Leila Dorling, Jonathan P. Tyrer, Susan Ingle, Yuan‐Tong Qi, Anne-Laure Vallier, Louise Hiller, Stephen R. Russell, Linda Jones, S. Bowden, Janet Dunn, Christopher Poole, Carlos Caldas, Paul D.P. Pharoah, Helena Earl	2014	82
11	Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery European Journal of Cardio-Thoracic Surgery ·I Ould Ahmedou, Andrea Marshall, Katrina Lê, Gyu Hwan Park, Kim Parker, Elaine Bevan-Smith, Chris Jordan, J.D. Gillies, Paula Agostini, Ehab Bishay, Maninder Kalkat, Richard Steyn, P. Rajesh, Janet Dunn, Babu Naidu	2013	54
12	Ethnicity data collection in the UK: the healthcare professional's perspective Diversity & Equality in Health and Care ·Gulnaz Iqbal, Mark Johnson, Ala Szczepura, Anil Gumber, Sue Wilson, Janet Dunn	2012	3
13	Improving ethnicity data collection for health statistics in the UK SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) ·Gulnaz Iqbal, Anil Gumber, Mark Johnson, Ala Szczepura, Sue Wilson, Janet Dunn	2009	15
14	Association of upper gastrointestinal surgeons of Great Britain and Ireland British journal of surgery ·John P. Neoptolemos, Janet Dunn, Ripu Kr. Gogoi, Jennifer Almond, K.H. Link, Junko Okahashi, Claudio Bassi, P. Pederzoli, Christos Dervenis, Laureano Fernández‐Cruz, F Lacaine, D. Spooner, David J. Kerr, Helmut Frieß, Ming Bu	2001	5
15	Invited papers – Clinical Trial Updates Session British Journal of Cancer ·早川弘一, Janet Dunn, Cathrine Solsletten, Jennifer Almond, H. G. Beger, K. H. Link, P. Pederzoli, Claudio Bassi, 唐先平, Laureano Fernández‐Cruz, F Lacaine, D. Spooner, Rachel Kerr, フィスコ株式チーム, Markus W. Büchler, Peter A. Clark, (unknown)	2000	1
16	A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix Annals of Oncology ·J. Herod, Andrea Burton, VLADIM�R �IMANSK�, Jeffrey Tobias, David Luesley, B Ruthensteiner, Janet Dunn, Christopher Poole	2000	34
17	Meta-analysis of adjuvant chemoradiotherapy and chemotherapy for resectable pancreatic cancer including the final results of the ESPAC-1 trial John P. Neoptolemos, Deborah Stocken, Janet Dunn, K Bakkevold, Johannes Jeekel, H. O. Douglass	1998	2
18	Pathogenesis of gall stones in Crohn's disease: an alternative explanation. Gut ·Ray Hutchinson, Pascal N. Tyrrell, Devinder Kumar, Janet Dunn, Brian Tsang, Robert Allan	1994	57
19	Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer European Journal of Cancer ·Paul Stonelake, N.J. Bundred, Ren-Shi Zhang, Peter R. Baker, (unknown), Paul Baker, William Gillespie, Janet Dunn, D. Spooner, J.M. Morrison, (unknown), G D Oates, FrantiRubl ́ ik, John P. Neoptolemos, R. Vivek	1994	24
20	Repeat testing for haematuria and underlying urological pathology British Journal of Urology ·Thomas Lynch, 牛素枝, Janet Dunn, M. A. HUGHES, D. M. A. WALLACE	1994	16

About Janet Dunn

Janet Dunn is a scholar working on Otorhinolaryngology, Cancer Research, Oncology, Hematology and Internal Medicine, having authored 253 papers that have together received 11.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (56 papers), Cancer Treatment and Pharmacology (26 papers), Multiple Myeloma Research and Treatments (25 papers), Head and Neck Cancer Studies (23 papers), Global Cancer Incidence and Screening (22 papers), Cancer Genomics and Diagnostics (18 papers), HER2/EGFR in Cancer Research (18 papers) and Pancreatic and Hepatic Oncology Research (17 papers). The work is most often cited by research in Internal Medicine (930 citations), Oncology (6.5k citations), Cancer Research (2.1k citations), Otorhinolaryngology (490 citations) and Pulmonary and Respiratory Medicine (3.0k citations). Janet Dunn has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include John P. Neoptolemos, Deborah Stocken, F Lacaine, D. Spooner, Laureano Fernández‐Cruz, Massimo Falconi, Helen Hickey, Andrea Marshall, Christos Dervenis and Mark T. Drayson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, British Journal of Cancer, Annals of Oncology and BJOG An International Journal of Obstetrics & Gynaecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact